Shares of POINT Biopharma Global Inc (PNT) are trading 7% higher at a price of $9.28 at the time of this writing. The stock's price action is flying high overhead it's peers on what is quickly becoming a somber day for the Health Care sector.
- POINT Biopharma Global (NASDAQ:PNT) has announced the closing of its public offering of 13,900,000 shares of common stock
- The company's price target has been lowered to $17.00 by Piper Sandler
POINT Biopharma Global Inc has been trading between a 52-week high of $10.98 and a 52-week low of $4.25. The stock has a market cap of $965 Million.
POINT Biopharma Global Inc. is a globally focused radiopharmaceutical company building a platform for the clinical development and commercialization of radioligands that fight cancer. POINT Biopharma Global Inc.